BMY
2026Q1BMOBristol-Myers Squibb Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS1.42
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move2.0%
IV front—
P/C full—
P/C front—
Features as of2026-04-29
Run-up
Close—
Ret 5d-2.1%
Ret 10d-0.5%
Ret 20d-5.0%
Ret 30d-3.6%
Actual EPS
1.58Beat
Estimated EPS1.42
Actual revenue
11.5B
Surprise %+11.3%
Beat / missBeat
Beat streak 44
Beat streak 88
Reaction
1-day stock reaction+5.0%
Implied vs actual
Implied 2.0%Actual 0.2%
Gap reaction+0.2%
Day result+5.2%
Next-day upYes
Realized / IV0.09×
Post tape
Post 5d-7.2%
Post 10d-6.3%
Post volume24.9M
Vol ×10d2.97×
Vol ×20d2.79×
Post range5.9%